Home > News & resources > News > Scope 48 - From the Director

Scope 48 - From the Director

30 July 2012

It is a privilege to work in research. To be in a position where we have the opportunity to make a difference to people’s lives is a gift none of us here at the Malaghan Institute take for granted.

Having said this, it is getting tougher each year to fund research programmes, both here in New Zealand and overseas. There is less government money coming to research and that which is funded is being broken up into smaller and smaller amounts. The only way to survive in the current climate is to stand out from the masses, so as an Institute we have set our scientists and staff very high goals.

One of these goals is to progress our cancer vaccine to the point where it is available to all New Zealanders seeking a better way to treat their cancer. In this issue of Scope we overview our cancer vaccine programme, from its inception at the Malaghan Institute in 1994, through to where we think this technology is heading in the future. This work requires patience, coordinated effort and considerable resources, but it is my absolute belief that we will succeed.